Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
A significant positive correlation was found between Lachnospiraceae and ALS functional rating scale scores (P < 0.005 and P < 0.001, respectively). Differential expression of purine metabolism ...
Nine out of 10 ALS cases occur in people with no family history of the disease, while the remainder of cases are genetically inherited, and are known as familial ALS. Most people are diagnosed ...
In a report released on March 7, Niraj Shah from Goldman Sachs maintained a Buy rating on ALS Ltd. (CPBLF – Research Report), with a price target of A$17.75. The company’s shares closed last ...
Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. The former retail manager first started experiencing symptoms more than 10 years ago ...
Typically, background checks take less than two minutes to complete and pose virtually no burden on mentally fit, law-abiding citizens. Notably, however, federal background check requirements do ...
A new study helps determine which blood tests are best at identifying and monitoring ALS. The study is published in the February 26, 2025, online issue of Neurology ® , the medical journal of the ...
“You can wake up one day and no longer do something that you did yesterday,” Robb said. In October 2024, Robb was diagnosed with ALS, a fatal disease that progressively destroys nerve cells ...
Although there are therapies for ALS/MND, there is “no cure,” the Cleveland Clinic explains, as muscles continue to atrophy, leading to “life-threatening outcomes.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback